ArticleBioinformatics (Oxford, England)2020
The ELIXIR Core Data Resources: fundamental infrastructure for the life sciences.
Article in Bioinformatics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed.
- How can biological databases support the new UN mechanism for benefit-sharing from digital sequence information?Scientific data · 2026Article
- pyBiodatafuse: extending interoperability of data using modular queries across biomedical resources.Bioinformatics (Oxford, England) · 2026Article
- BRENDA in 2026: a Global Core Biodata Resource for functional enzyme and metabolic data within the DSMZ Digital Diversity.Nucleic acids research · 2026Article
- The ProteomeXchange consortium in 2026: making proteomics data FAIR.Nucleic acids research · 2026Article
- The European Nucleotide Archive in 2025.Nucleic acids research · 2026Article
- The Reactome Knowledgebase 2026.Nucleic acids research · 2026Article
- SILVA in 2026: a global core biodata resource for rRNA within the DSMZ digital diversity.Nucleic acids research · 2026Article
- Usage and impact of global biodata resources.Bioinformatics advances · 2026Article
- National biodiversity data infrastructures: ten essential functions for science, policy, and practice.Bioscience · 2025Article
- EMBL's European Bioinformatics Institute (EMBL-EBI) in 2024.Nucleic acids research · 2025Article
- The PRIDE database at 20 years: 2025 update.Nucleic acids research · 2025Article
- Advancing service offerings in food and nutrition metrology: the updated METROFOOD-RI service chart.Frontiers in nutrition · 2025Article
- FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden.Cancers · 2024Article
- Ensembl 2024.Nucleic acids research · 2024Article
- The European Nucleotide Archive in 2023.Nucleic acids research · 2024Article
- The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.Nucleic acids research · 2024Article
- Using text-mining to measure the scientific impact and legacy of ELIXIR, a distributed research infrastructure for life science data.F1000Research · 2024Article
- Perspectives on tracking data reuse across biodata resources.Bioinformatics advances · 2024Article
- Features of a FAIR vocabulary.Journal of biomedical semantics · 2023Article
- Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New Drugs.Marine drugs · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
supplementary informationSupplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.